Franklin Resources’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537K | Buy |
47,783
+13,662
| +40% | +$153K | ﹤0.01% | 2280 |
|
|
2025
Q1 | $156K | Buy |
34,121
+47
| +0.1% | +$215 | ﹤0.01% | 2737 |
|
|
2024
Q4 | $192K | Sell |
34,074
-81
| -0.2% | -$457 | ﹤0.01% | 2648 |
|
|
2024
Q3 | $172K | Buy |
34,155
+5,914
| +21% | +$29.7K | ﹤0.01% | 2660 |
|
|
2024
Q2 | $138K | Buy |
28,241
+3,319
| +13% | +$16.2K | ﹤0.01% | 2627 |
|
|
2024
Q1 | $331K | Buy |
24,922
+12
| +0% | +$159 | ﹤0.01% | 2419 |
|
|
2023
Q4 | $347K | Buy |
+24,910
| New | +$347K | ﹤0.01% | 2099 |
|